Get 40% Off
💰 Buffett reveals a $6.7B stake in Chubb. Copy the full portfolio for FREE with InvestingPro’s Stock Ideas toolCopy Portfolio

UPDATE 2-Weak German business morale, vaccine delays push European stocks to 2-week low

Published 25/01/2021, 10:44
© Reuters.
UK100
-
FCHI
-
PHG
-
LHAG
-
AIRF
-
EDF
-
SGREN_OLD
-
SXRP
-
STOXX
-
RYA
-
SX8P
-
WAFGn
-
6488
-
PRX
-
ENR1n
-

(For a Reuters live blog on U.S., UK and European stock
markets, click LIVE/ or type LIVE/ in a news window)
* Tech sector boosts markets globally
* Banks, oil, travel stocks hit by lockdown fears
* Prosus rallies to an all-time high

(Updates to market close)
By Sruthi Shankar
Jan 25 (Reuters) - European shares closed at two-week lows
on Monday as a slump in German business morale underscored the
damage from tighter COVID-19 restrictions, while investors
feared a slow vaccine rollout could further delay an economic
recovery.
The pan-European STOXX 600 index .STOXX reversed early
gains and finished 0.8% lower. The German DAX .GDAXI fell
1.7%, France CAC 40 .FCHI was down 1.6% and the UK's FTSE 100
.FTSE declined 0.8%.
The Ifo economic institute's business climate index fell to
90.1 in January from an upwardly revised reading of 92.2 in
December, while a Reuters poll had forecast a reading of 91.8.
The German economy, Europe's largest, will likely reach its
pre-pandemic levels in mid-2022, according to a draft document
prepared by the economy ministry, seen by Reuters. "German Q1 GDP now looks likely to fall by at least 1% qoq,
assuming that the restrictions for retail and services will only
be gradually lifted after Feb. 14," Deutsche Bank's chief
economist, Stefan Schneider, wrote in a note.
"Hence, our 4-1/2% forecast for the year as a whole looks
somewhat ambitious, but given the overall uncertainty we
currently see no real need to lower it."
Economy-linked banking .SX7P , auto .SXAP , oil & gas
.SXEP and travel & leisure .SXTP stocks took the biggest
hit, falling between 1.9% and 3%.
Markets took a turn for the worse after U.S. drugmaker Merck
MRK.N said it would end development of its two COVID-19
vaccines.
Pfizer PFE.N announcing delays of nearly a month to its
COVID-19 vaccine shipments to the European Union earlier this
month, while AstraZeneca AZN.L has announced a large cut in
supplies to the bloc.
British Prime Minister Boris Johnson said he was looking at
toughening border quarantine rules because of the risk of
"vaccine-busting" coronavirus variants. British Airways-owner IAG IACG.L , Ryanair RYA.I ,
Lufthansa LHAG.DE and Air France KLM AIRF.PA fell between
3.3% and 7.7%, while retailers .SXRP fell 1.5%.
Several Spanish regions ramped up anti-coronavirus measures,
while France was looking at a third national lockdown.
Technology stocks .SX8P gave back early gains, but losses
were modest as their U.S. peers traded at all-time highs.
Finnish telecom equipment maker Nokia NOKIA.HE jumped
12.9%, while technology investor Prosus PRX.AS gained 3.6% to
hit an all-time high.
Investors sought refuge in defensive sectors such as
telecoms .SXKP and healthcare .SXDP which gained 0.9% and
0.7%, respectively.
French state-controlled power group EDF EDF.PA slumped
15.6% to the bottom of STOXX 600 after broadcaster BFM Business
reported that the European Commission wanted a further six
months of talks on a planned restructuring. A source in the French finance ministry denied the report.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.